156 related articles for article (PubMed ID: 26786256)
21. CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study.
Fuster F; Vargas JI; Jensen D; Sarmiento V; Acuña P; Peirano F; Fuster F; Arab JP; Martínez F;
Vaccine; 2016 Apr; 34(16):1889-95. PubMed ID: 26945101
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of immune responses to combined hepatitis A and B vaccine in HIV-infected children and children on immunosuppressive medication.
Belderok SM; Sonder GJ; van Rossum M; van Dijk-Hummelman A; Hartwig N; Scherpbier H; Geelen S; Speksnijder AG; Baaten G; van den Hoek A
Vaccine; 2013 Aug; 31(38):4156-63. PubMed ID: 23845818
[TBL] [Abstract][Full Text] [Related]
23. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
Krairittichai U; Sethakarun S
J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
[TBL] [Abstract][Full Text] [Related]
24. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose.
Fonseca MO; Pang LW; de Paula Cavalheiro N; Barone AA; Heloisa Lopes M
Vaccine; 2005 Apr; 23(22):2902-8. PubMed ID: 15780739
[TBL] [Abstract][Full Text] [Related]
25. Three vs Four Dose Schedule of Double Strength Recombinant Hepatitis-B Vaccine in HIV-infected Children: A Randomized Controlled Trial.
Jain P; Dewan P; Gomber S; Kashyap B; Raizada A
Indian Pediatr; 2021 Mar; 58(3):224-228. PubMed ID: 33713056
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of double-dose hepatitis B rescue vaccination in HIV-infected patients.
Psevdos G; Kim JH; Groce V; Sharp V
AIDS Patient Care STDS; 2010 Jul; 24(7):403-7. PubMed ID: 20586648
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
Bailey CL; Smith V; Sands M
Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel.
Kalchiem-Dekel O; Grupel D; Bouchnik L; Sikuler E; Ben-Yakov G
J Gastroenterol Hepatol; 2015 Dec; 30(12):1782-7. PubMed ID: 26101816
[TBL] [Abstract][Full Text] [Related]
29. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with seroconversion after standard dose hepatitis B vaccination and high-dose revaccination among HIV-infected patients.
Pettit NN; DePestel DD; Malani PN; Riddell J
HIV Clin Trials; 2010; 11(6):332-9. PubMed ID: 21239361
[TBL] [Abstract][Full Text] [Related]
31. Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.
Seremba E; Ocama P; Ssekitoleko R; Mayanja-Kizza H; Adams SV; Orem J; Katabira E; Reynolds SJ; Nabatanzi R; Casper C; Phipps W
Vaccine; 2021 Feb; 39(8):1265-1271. PubMed ID: 33516601
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco.
Haban H; Benchekroun S; Sadeq M; Benjouad A; Amzazi S; Oumzil H; Elharti E
BMC Public Health; 2017 Sep; 17(1):752. PubMed ID: 28962610
[TBL] [Abstract][Full Text] [Related]
33. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
[TBL] [Abstract][Full Text] [Related]
34. Association between hepatitis B vaccine antibody response and CD4 reconstitution after initiation of combination antiretroviral therapy in HIV-infected persons.
Allen K; Mesner O; Ganesan A; O'Bryan TA; Deiss RG; Agan BK; Okulicz JF
BMC Infect Dis; 2015 May; 15():203. PubMed ID: 25928043
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.
Chonwattana W; Raengsakulrach B; Holtz TH; Wasinrapee P; Tongtoyai J; Chaikummao S; Pattanasin S; McNicholl JM; van Griensven F; Curlin ME
Vaccine; 2016 Apr; 34(17):2044-50. PubMed ID: 26685092
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda.
Mutwa PR; Boer KR; Rusine JB; Muganga N; Tuyishimire D; Reiss P; Lange JM; Geelen SP
Pediatr Infect Dis J; 2013 Mar; 32(3):246-51. PubMed ID: 22976050
[TBL] [Abstract][Full Text] [Related]
37. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients.
Cruciani M; Mengoli C; Serpelloni G; Lanza A; Gomma M; Nardi S; Rimondo C; Bricolo F; Consolaro S; Trevisan M; Bosco O
Vaccine; 2009 Jan; 27(1):17-22. PubMed ID: 18984022
[TBL] [Abstract][Full Text] [Related]
38. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
[TBL] [Abstract][Full Text] [Related]
39. Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.
Overton ET; Kang M; Peters MG; Umbleja T; Alston-Smith BL; Bastow B; Demarco-Shaw D; Koziel MJ; Mong-Kryspin L; Sprenger HL; Yu JY; Aberg JA
Vaccine; 2010 Aug; 28(34):5597-604. PubMed ID: 20600512
[TBL] [Abstract][Full Text] [Related]
40. Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression.
Bunupuradah T; Ananworanich J; Pancharoen C; Petoumenos K; Prasitsuebsai W; Wongngam W; Ubolyam S; Sriheara C; Lange J; Phanuphak P; Puthanakit T
Vaccine; 2011 Apr; 29(16):2962-7. PubMed ID: 21329776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
